|
|
|
Insider
Information: |
Mammen Mathai |
Relationship: |
EVP, Pharm, R&D |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
844,344 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$15,416,621 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
844,344 |
|
|
Total
Value |
$15,416,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
SVP, Research & Early ... |
2014-08-20 |
334,040 |
|
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
SVP, Research & Develo... |
2016-03-15 |
288,111 |
|
0 |
Premium* |
|
10x Genomics, Inc. |
TXG |
|
2024-06-11 |
180,259 |
2021-06-11 |
0 |
Premium* |
|
Johnson & Johnson |
JNJ |
EVP, Pharm, R&D |
2022-02-15 |
41,934 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2009-05-20 |
4 |
D |
$14.06 |
$15,058 |
D/D |
(1,071) |
103,815 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2009-08-20 |
4 |
D |
$15.65 |
$16,761 |
D/D |
(1,071) |
102,744 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2009-11-20 |
4 |
D |
$14.04 |
$15,444 |
D/D |
(1,100) |
101,644 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
126,644 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-02-20 |
4 |
D |
$10.22 |
$13,470 |
D/D |
(1,318) |
125,326 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-05-20 |
4 |
D |
$13.02 |
$21,782 |
D/D |
(1,673) |
123,653 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-08-20 |
4 |
D |
$14.00 |
$23,394 |
D/D |
(1,671) |
121,982 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-09-01 |
4 |
S |
$12.84 |
$56,701 |
D/D |
(4,416) |
117,566 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-09-07 |
4 |
OE |
$8.53 |
$54,995 |
D/D |
6,451 |
124,017 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
136,517 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2010-11-20 |
4 |
D |
$22.52 |
$57,021 |
D/D |
(2,532) |
133,985 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-01-28 |
4 |
OE |
$8.53 |
$83,869 |
D/D |
9,838 |
143,823 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
256,323 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-02-18 |
4 |
AS |
$23.12 |
$85,567 |
D/D |
(3,701) |
252,622 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-02-20 |
4 |
D |
$22.50 |
$72,900 |
D/D |
(3,240) |
249,382 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-05-20 |
4 |
D |
$25.48 |
$57,203 |
D/D |
(2,245) |
247,137 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-08-20 |
4 |
D |
$17.50 |
$39,340 |
D/D |
(2,248) |
244,889 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-09-01 |
4 |
OE |
$8.53 |
$27,493 |
D/D |
3,225 |
248,114 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2011-11-20 |
4 |
D |
$22.34 |
$50,265 |
D/D |
(2,250) |
245,864 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
250,864 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-02-20 |
4 |
D |
$18.54 |
$180,709 |
D/D |
(9,747) |
241,117 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-05-20 |
4 |
D |
$20.33 |
$77,905 |
D/D |
(3,832) |
237,285 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-08-13 |
4 |
AS |
$25.68 |
$643,461 |
D/D |
(25,000) |
212,285 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-08-20 |
4 |
D |
$27.01 |
$125,434 |
D/D |
(4,644) |
207,641 |
0 |
- |
|
INVA |
Innoviva Inc |
SVP, Research & Early Clin Dev |
|
2012-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
212,641 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|